title: Tibolone reduces osteoporotic fracture risk and breast cancer risk, but increases the risk of stroke.
authors.forename: Nilson R
authors.initials: NR
authors.lastname: de Melo
authors.forename: Luciano M
authors.initials: LM
authors.lastname: Pompei
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000517:prevention & control*; D020847:Estrogen Receptor Modulators / Q000009:adverse effects / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009652:Norpregnenes / Q000009:adverse effects / Q000494:pharmacology*; D058866:Osteoporotic Fractures / Q000517:prevention & control*; D020521:Stroke / Q000139:chemically induced*
chemical_list: D020847:Estrogen Receptor Modulators; D009652:Norpregnenes; C027385:tibolone